Treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibody
- 1 February 1987
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 82 (2), 202-206
- https://doi.org/10.1016/0002-9343(87)90056-8
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complexCell, 1982
- Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu-2a antibodies.The Journal of Experimental Medicine, 1982
- Use of Monoclonal Antibodies to T-Cell Subsets for Immunologic Monitoring and Treatment in Recipients of Renal AllograftsNew England Journal of Medicine, 1981
- Monoclonal Antibodies Defining Distinctive Human T Cell Surface AntigensScience, 1979
- Some recent advances in cardiac pathologyHuman Pathology, 1979
- Techniques for right and left ventricular endomyocardial biopsyThe American Journal of Cardiology, 1978